📖 Our Story Ctrl + Alt + Win
How We Started
We entered this work through Abuja’s crowded pharmacies and bustling street markets—Garki, Utako, and Nyanya—where medicines flow through communities without verification, transparency, or trust. At first, what we saw appeared to be a supply chain problem: counterfeit drugs entering through opaque distribution networks, pharmacies unable to verify incoming batches, and street vendors selling medicines from unmarked containers. We initially assumed the counterfeit medicine problem was mostly a technical or logistics issue. But as we spoke with pharmacists, patients, local vendors, and healthcare workers, we realized the deeper challenge wasn’t about tracking or distribution systems. It was about a breakdown of trust in the healthcare system itself.
What We Heard and Observed
A mother in Nyanya told us: “I once bought malaria drugs that did nothing. My child stayed sick for days.” A pharmacist in Utako shared their helplessness: “We sometimes receive batches that look suspicious, but we can’t verify them. We lose trust when patients come back saying the drugs didn’t work.” A clinic nurse explained: “When treatments fail because of fake drugs, patients stop trusting us—even though it’s not our fault.”
From the other side, a street vendor casually admitted: “People buy from me because it’s cheap. They don’t ask where it comes from.” A student in Garki expressed what many felt: “If I could just scan and confirm a drug is real, that would save many people.”
What became visible was a devastating pattern of normalized danger. People openly shared experiences of buying drugs that “did nothing.” Pharmacists admitted receiving suspicious batches with no verification tools. We observed crowded pharmacies with no verification systems visible, street vendors selling medicines from unmarked containers, price-driven purchases overriding safety concerns, and no digital tools for authenticity checking. The same frustrations repeated everywhere: “I don’t know if this medicine is real,” “The drugs didn’t work—my child is still sick,” “We receive suspicious batches but have no way to check,” “Street drugs are cheaper, so people buy them,” “Fake drugs are everywhere—it’s normal now.”
What moved us most deeply was the impossible choice low-income families face. When someone is sick, they buy immediately—there’s no time to verify. People choose cheap drugs knowing they might be fake, simply because they can’t afford the alternative. The most heartbreaking realization: People often choose cheap drugs knowing they might be fake, simply because they can’t afford the alternative. These recurring experiences and the daily flow of risk are documented more fully in our Community Essence Map.
Where the System Breaks
As we mapped the ecosystem, we saw how Nigeria’s pharmaceutical supply chain operates through profound opacity and disconnection, creating vulnerability at every level. The issue is not just about tracking drugs—it is about people who feel unprotected by the system that’s supposed to safeguard their health.
The breakdown happens across multiple layers. No easy method exists to confirm drug authenticity at point of purchase—even pharmacists cannot verify incoming batches reliably. Manufacturers, distributors, and pharmacies work in silos with no visibility into each other’s operations, meaning counterfeit drugs can enter at any point without detection or accountability. Street vendors supply fake medicines freely, capitalizing on affordability pressures with no oversight, creating an informal economy that thrives on the gap between demand for affordable medicine and lack of verification systems.
The trust crisis compounds across the ecosystem. Health workers lose credibility because counterfeit drugs make treatments fail, eroding confidence in the entire healthcare system—even genuine healthcare providers suffer reputation damage from systemic failures beyond their control. Fake anti-malarials and antibiotics frequently enter the market from unregulated distributors. Some private hospitals still lack proper tracking systems. Many youths and parents expressed concern about “fake drugs everywhere” but feel powerless to detect them.
The result is treatment failure, drug resistance, preventable deaths, and public distrust in healthcare. Patients cannot confidently verify if their drugs are genuine. Pharmacists struggle to trace the true source of medicine batches. Doctors have no secure way to enforce prescription-only access. The most vulnerable populations—low-income families, children, elderly, chronic illness patients, rural migrants—bear the highest risk. This is not just a logistics problem—it is a life-and-death trust failure inside Nigeria’s medicine ecosystem. The roles, constraints, and power dynamics across this fragmented supply chain are explored further in our Stakeholder Map.
Naming the Real Challenge
We initially assumed the challenge was building better supply chain tracking—something to help pharmacies and distributors manage inventory and trace drug origins more efficiently. But that framing was incomplete. After speaking with pharmacists, patients, and local vendors, we realized the deeper challenge is a breakdown of trust in the healthcare system.
People aren’t just losing money—they’re losing faith in the entire healthcare system that’s supposed to protect them. The real challenge isn’t better inventory software or improved distribution networks. The challenge is that in Abuja, many residents face constant uncertainty about whether the medicines they buy are genuine, as counterfeit drugs circulate through unregulated vendors and opaque supply chains, affecting health outcomes, increasing treatment failure, and eroding trust in healthcare.
Counterfeit and substandard medicines circulate daily through opaque supply chains, unreliable distributors, and unregulated street vendors. What’s broken is the fundamental relationship between everyone in the pharmaceutical ecosystem: patients cannot verify authenticity, pharmacists cannot protect customers, doctors cannot ensure prescriptions reach intended patients, and manufacturers cannot protect their brands or identify counterfeit entry points.
Through conversations and observation, we saw that the community is not asking for complex systems or advanced technology. They simply want confidence—a way to know their medicine is real, safe, and trustworthy. This understanding shaped our Problem Statement and shifted our thinking from supply chain logistics to building trust infrastructure that restores dignity and safety.
How We Changed
This process fundamentally changed how we think about pharmaceutical technology. Our understanding evolved from a purely technical idea into a human-centered mission. During our exploration across Abuja, our team’s perspective changed significantly as we moved from thinking about this as a logistics problem to understanding it as a human vulnerability and trust problem.
What surprised us most was how normalized the risk of fake medicines feels to the community. The danger is not hypothetical—it is a daily threat to health and survival. We were moved by hearing a mother describe how malaria drugs she bought for her child had no effect, a pharmacist express helplessness when receiving suspicious batches, a clinic nurse explain how they lose patient trust when treatments fail, and a street vendor casually admit people buy from him “because it’s cheap” without questioning origins.
We also learned the specific nature of community needs. Patients want simple, quick verification: “How do I know this medicine is real? Where did this drug come from? Is it safe for my child?” Pharmacists want transparent supply chain visibility: “How do I verify suspicious batches? How do I protect my customers and my reputation?” Doctors want accountability: “Are my prescriptions reaching the right patients? Why are treatments failing?” They want a solution that is simple, quick, and easy to adopt in daily routines.
The project is not just about building software—it is about supporting a community that deserves safety, certainty, and dignity in the medicines they rely on. Our internal evolution from technical focus to human-centered mission is explored more deeply in our Team Reflection.
The Direction Forward
This work points toward a future where Abuja residents no longer live with constant uncertainty about medicine authenticity—where every patient can verify their medicine is genuine with a simple scan, pharmacists protect customers through blockchain-verified supply chains, doctors know their prescriptions reach intended patients, and counterfeit drugs are identified and stopped before causing harm.
The opportunity is to build MediSure as a Cardano-powered medicine verification and prescription management system that restores trust, safety, and transparency throughout drug distribution. The solution must make verification simple and instant: medicine batches minted as unique on-chain assets, QR codes generated for each batch linking to blockchain records, pharmacies and distributors updating the blockchain as drugs move through the supply chain, and patients scanning QR codes to instantly verify authenticity.
But the technology must serve actual community needs across vulnerability divides. It must work for patients who cannot afford expensive verified pharmacies but deserve protection from fake drugs. It must give pharmacists tools to verify incoming stock and build customer trust. It must enable doctors to issue secure digital prescriptions ensuring controlled access to sensitive drugs. It must provide manufacturers with tamper-proof tracking to protect brand reputation and identify counterfeit entry points. And it must support NAFDAC and regulators with real-time visibility for better enforcement.
Every step—from manufacturer to patient—must become immutable, verifiable, and tamper-proof. The system must provide complete supply chain transparency while remaining simple enough for daily adoption. It must address the impossible tension between affordability and safety by making verification free and instant.
For mothers buying medicine for sick children, pharmacists struggling to protect their reputation, doctors watching treatments fail from counterfeit drugs, and low-income families forced to choose between cost and safety, trustworthy pharmaceutical infrastructure isn’t just convenient—it’s lifesaving. The direction forward is building the platform that turns the current cycle of uncertainty and preventable harm into a foundation of verified authenticity, restored confidence, and protected health.
We’re not just fighting counterfeit drugs—we’re fighting for trust in healthcare systems, safety for vulnerable patients, dignity for people making impossible choices between affordability and safety, and accountability throughout the pharmaceutical supply chain.
MediSure is about restoring the fundamental right to know that your medicine will help, not harm.